Wikidata

(Q65402422)

English

Entyvio (Vedolizumab) Long Term Safety Study

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
Entyvio PASS (English)
0 references
title
Entyvio (Vedolizumab) Long-term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab to Other Biologic Agents in Patients With Ulcerative Colitis or Crohn's Disease (English)
0 references
medical condition
colitis
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
Estonia
0 references
France
0 references
Germany
0 references
Greece
0 references
Ireland
0 references
Israel
0 references
Italy
0 references
Netherlands
0 references
Norway
0 references
Portugal
0 references
Slovenia
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
United Kingdom
0 references
start time
31 March 2015
0 references
end time
1 July 2021
0 references
number of participants
5,000
0 references
research site
Stanford University
0 references
AdventHealth Orlando
0 references
Dartmouth University
0 references
New York University
0 references
University of Virginia
0 references
Tel Aviv University
0 references
Barts Health NHS Trust
0 references
Royal Gwent Hospital
0 references
University of Alabama
0 references
Augusta University
0 references
University of Michigan
0 references
Saint Louis University
0 references
Lenox Hill Hospital
0 references
Aarhus University
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65402422&oldid=2234430433"